• Trickey A, Sabin CA, Burkholder G, Crane H, d'Arminio Monforte A, Egger M, Gill MJ, Grabar S, Guest JL, Jarrin I, Lampe FC, Obel N, Reyes JM, Stephan C, Sterling TR, Teira R, Touloumi G, Wasmuth JC, Wit F, Wittkop L, Zangerle R, Silverberg MJ, Justice A, Sterne JAC. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. The lancet. HIV. 2023 May 1; 10(5):e295-e307.
• Bingaman A, Hamilton A, Houpt B, Olivero R, Fair C. "Nothing is ever going to change if we don't start advocating for our child.": Community-level disclosure and stigma management strategies among parents of internationally adopted children living with PHIV. Frontiers in public health. 2023 Mar 17; 11:1091335.
• Womack JA, Murphy TE, Leo-Summers L, Bates J, Jarad S, Gill TM, Hsieh E, Rodriguez-Barradas MC, Tien PC, Yin MT, Brandt CA, Justice AC. Assessing the contributions of modifiable risk factors to serious falls and fragility fractures among older persons living with HIV. Journal of the American Geriatrics Society. 2023 Mar 13.
• Akgün KM, Krishnan S, Tate J, Bryant K, Pisani MA, Lo Re V, Rentsch CT, Crothers K, Gordon KS, Justice AC, VACS project team. Delirium among people aging with and without HIV: Role of alcohol and Neurocognitively active medications. Journal of the American Geriatrics Society. 2023 Feb 14.
• Soares C, Kwok M, Boucher KA, Haji M, Echouffo-Tcheugui JB, Longenecker CT, Bloomfield GS, Ross D, Jutkowtiz E, Sullivan JL, Rudolph JL, Wu WC, Erqou S. Performance of Cardiovascular Risk Prediction Models Among People Living With HIV: A Systematic Review and Meta-analysis. JAMA cardiology. 2023 Feb 1; 8(2):139-149.

» View more Citations

• VA Successfully Implements Interferon-free Treatment for Hepatitis C Virus in Previously Undertreated Patient Populations
  This study examined the adoption of interferon-free treatment for hepatitis C virus (HCV) in VA to learn who received this therapy and whether the limitations of interferon-containing treatments have been overcome, including low rates of use among VA healthcare users who are African American or Hispanic, and among those with HCV-HIV co-infection. Findings showed that with the advent of interferon-...
  
  Date: March 7, 2018
• Evidence Review Identifies Modest Mortality Disparities among Racial and Ethnic Minority Groups in VA Healthcare
  To support VA’s efforts to better understand the scale and determinants of disparities in racial and ethnic mortality – and to develop interventions to reduce disparities, investigators from the VA Evidence-based Synthesis Program (ESP) Coordinating Center in Portland, OR conducted an evidence review of mortality disparities specific to VA. Findings showed that although VA’s equal access healthcar...
  
  Date: March 1, 2018
• Racial Disparities in HIV Quality of Care that May Extend to Common Comorbid Conditions
  To more fully understand patterns of racial disparities in the quality of care for persons with HIV infection, this study examined a national cohort of Veterans in care for HIV in the VA healthcare system during 2013. Findings showed that racial disparities were identified in quality of care specific to HIV infection – and in the care of common comorbid conditions. Blacks were less likely than whi...
  
  Date: September 22, 2016
• New Guidelines May Significantly Decrease Cost for Testing Immune Function in Veterans with HIV
  In 2012, the Department of Health and Human Services recommended CD4 testing in patients with HIV every 3 to 6 months – except in patients with consistently suppressed virus and sustained CD4 cell count, who could be tested every 6 to 12 months. In 2014, updated guidelines recommended that in individuals with viral suppression, CD4 testing be considered either optional or annual, depending on the ...
  
  Date: July 1, 2016
• Consequences of Notifying VA Patients about Potential Exposure to Large-Scale Adverse Events
  This study sought to determine the intended and unintended consequences of patient notification following a large-scale adverse event (LSAE) within the VA healthcare system, which systematically looks for LSAEs, tracks potentially exposed patients, and communicates with them after LSAE notification. Findings showed that more than two-thirds of potentially exposed patients returned for HCV, HBV, an...
  
  Date: May 1, 2015

» View more Publication Briefs

» View more Studies

• AppendixIV-EvidenceTables.xls

  DIABETES &LDRAFT VA-ESP&C&P of &N&R&D 5. HIV HCV Author, Year Title Aims Study design...diagnostic and therapeutic care for HIV-infected individuals with PCP. Retrospective

• Telehealth Collaborative Care for Veterans with HIV Living in Rural Settings || In Progress

  Collaborative Care for Veterans with HIV Living in Rural Settings Feature Article...largest provider of care for persons with HIV in the U.S., with more than 26,000 Veterans

• Prevalence of and Interventions to Reduce Health Disparities in Vulnerable Veteran Populations: A Map of the Evidence

  ...and Information Set HF Heart failure HIV Human immunodeficiency virus HRME High...[CKD], Human Immunodeficiency Virus [HIV], diabetes, posttraumatic stress disorder

• Screening for Male Osteoporosis: A Systematic Review

  ...populations such as individuals with HIV or those on androgen deprivation therapy...prior ATD therapy, people living with HIV or rheumatoid arthritis) had low/moderate

• HSR&D Impacts

  ...data on HIV care The VA is the single largest provider of care to HIV-infected...about HIV. This study used 1993 and 1994 data from VA's national HIV Registry

» View more Publications

» View more Cyberseminars

Videos

There are currently no videos for this topic.

Podcasts

There are currently no podcasts for this topic.

Other Resources

• Visit the HIV/AIDs information section of the VA's Office of Public Health website.
• Visit the Centers for Disease Control & Prevention HIV information section.
• Learn more about all VA research related to HIV on the VA Office of Research & Development’s infectious disease topic page.